New York, NY – Spreemo, a healthcare platform providing evidence-based quality metrics and predictive analytics to facilitate high-quality and collaborative patient care, has named Daniel Elgort, Ph.D., as its Vice President of Healthcare Analytics. Most recently, he served as Director and Global Lead of Healthcare Big Data Analytics Research at Philips. In his new role, Dr. Elgort will oversee the continued expansion of Spreemo’s data analytics initiatives in radiology, as well as other medical disciplines.
“We’ve been uniquely successful not only in creating objective measures to help identify high-quality radiology providers, but also in receiving widespread support from both the provider and payer communities. Establishing a currency of quality that all stakeholders – payors and providers alike – can agree upon is fundamental to a more transparent and value-based healthcare system,” said Spreemo CEO and Co-founder Ron Vianu. “We’re very excited to leverage Daniel’s expertise as we expand our efforts to further and analytically refine our understanding of quality in order to address the increasing focus of our partners – that is, improving patient outcomes efficiently across the entire continuum of patient care.”
Dr. Elgort has conducted extensive healthcare research and is the primary author of over 50 peer-reviewed journal articles and conference abstracts. He holds over 40 pending or granted patents and was the recipient of Phase I and II DARPA grants. He has a B.S. from Johns Hopkins University and a Ph.D. in biomedical engineering from Case Western Reserve University.
“The creation and promotion of objective quality metrics is one of the great challenges and opportunities for reforming our healthcare system,” said Dr. Elgort. “I’m impressed by the strides Spreemo has made in gaining buy-in from payers and the radiology community, and I’m extremely enthusiastic about the opportunity to work with Spreemo and its partners to broaden the scope of its data-rooted infrastructure and make a real impact on patient outcomes.”